Literature DB >> 8295987

Radiation therapy in the unresectable cavernous hemangioma of the liver.

L Gaspar1, F Mascarenhas, M S da Costa, J S Dias, J G Afonso, M E Silvestre.   

Abstract

Hemangioma is the most common benign neoplasm of the liver, for which a 'wait and see' policy has been advised when it is small or without symptoms. Surgery is the treatment of choice of these tumors when marked symptomatology is present. However, some of these lesions cannot be excised due to their size, multiplicity, location or medical conditions. In these patients, radiotherapy has been reported to give good results with minor morbidity, suspending the tumor growth and decreasing the symptomatology. Seven symptomatic patients were treated with radiotherapy with a dose of 15-30 Gray in 15-22 fractions. Improvement of the quality of life was observed in all patients and the regression of the tumor volume was confirmed by computed tomography in five, with a follow-up ranging from 40 to 67 months.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295987     DOI: 10.1016/0167-8140(93)90172-5

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  16 in total

1.  CT and MRI findings correlate with the time-course of unresectable cavernous haemangioma of the liver after fractionated radiotherapy.

Authors:  H-L Lee; T-S Chung; S-W Chen; W T Lao
Journal:  Br J Radiol       Date:  2012-03       Impact factor: 3.039

2.  Superselective Transarterial Chemoembolization as an Alternative to Surgery in Symptomatic/Enlarging Liver Hemangiomas.

Authors:  İlgin Özden; Arzu Poyanlı; Yılmaz Önal; Ali Aslan Demir; Gültekin Hoş; Bülent Acunaş
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

3.  Surgical Management for Giant liver Hemangiomas Greater Than 20 cm in Size.

Authors:  Hui Jiang; Zheyu Chen; Pankaj Prasoon; Hong Wu; Yong Zeng
Journal:  Gut Liver       Date:  2011-06-28       Impact factor: 4.519

4.  Laparoscopic radiofrequency ablation of hepatic cavernous hemangioma. A preliminary experience with 27 patients.

Authors:  R-F Fan; F-L Chai; G-X He; L-X Wei; R-Z Li; W-X Wan; M-D Bai; W-K Zhu; M-L Cao; H-M Li; S-Z Yan
Journal:  Surg Endosc       Date:  2005-12-09       Impact factor: 4.584

5.  Management of Symptomatic Hepatic "Mega" Hemangioma.

Authors:  William A Ketchum; Kevin M Lin-Hurtubise; Emily Ochmanek; Kelli Ishihara; Robert D Rice
Journal:  Hawaii J Med Public Health       Date:  2019-04

6.  Preoperative arterial embolization of large liver hemangiomas.

Authors:  Serdar Topaloğlu; Şükrü Oğuz; Orhan Kalaycı; M Halil Öztürk; Adnan Çalık; Hasan Dinç; Ümit Çobanoğlu
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

7.  Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review.

Authors:  Parsia A Vagefi; Ingo Klein; Bruce Gelb; Bilal Hameed; Stephen L Moff; Jeff P Simko; Oren K Fix; Helge Eilers; John R Feiner; Nancy L Ascher; Chris E Freise; Nathan M Bass
Journal:  J Gastrointest Surg       Date:  2010-06-12       Impact factor: 3.452

8.  A case of a ruptured sclerosing liver hemangioma.

Authors:  Haris Papafragkakis; Martin Moehlen; Monica T Garcia-Buitrago; Beatrice Madrazo; Eddie Island; Paul Martin
Journal:  Int J Hepatol       Date:  2011-05-31

9.  Giant cavernous hepatic hemangioma shrunk by use of sorafenib.

Authors:  Satoyoshi Yamashita; Kohsuke Okita; Katsunori Harada; Atsuyoshi Hirano; Teruaki Kimura; Akira Kato; Kiwamu Okita
Journal:  Clin J Gastroenterol       Date:  2012-11-29

10.  Obstructive jaundice caused by a giant liver hemangioma with Kasabach-Merritt syndrome: a case report.

Authors:  Takuya Yano; Tsuyoshi Kobayashi; Shintaro Kuroda; Hironobu Amano; Hirotaka Tashiro; Hideki Ohdan
Journal:  Surg Case Rep       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.